Source:http://linkedlifedata.com/resource/pubmed/id/10078741
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1999-4-30
|
pubmed:abstractText |
Degenerative cerebellar ataxia with autoantibodies against glutamic acid decarboxylase (GAD) is a rare disorder and may represent a subset of ataxias previously classified as idiopathic. The authors report a patient with progressive cerebellar ataxia, insulin-dependent diabetes mellitus, and GAD antibodies who responded to i.v. immunoglobulins.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-3878
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
857-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10078741-Aged,
pubmed-meshheading:10078741-Autoantibodies,
pubmed-meshheading:10078741-Cerebellar Ataxia,
pubmed-meshheading:10078741-Female,
pubmed-meshheading:10078741-Glutamate Decarboxylase,
pubmed-meshheading:10078741-Humans,
pubmed-meshheading:10078741-Immunoglobulins, Intravenous
|
pubmed:year |
1999
|
pubmed:articleTitle |
Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
|
pubmed:affiliation |
Department of Neurology, University of Tübingen, Germany. michael.abele@uni-bonn.de
|
pubmed:publicationType |
Journal Article,
Case Reports
|